dvm36014d
Boehringer Ingelheim announces research and development facility expansion
The state-of-the-art research and development center in Georgia will help improve the health and wellbeing of animals ...
With $66 million R&D center, Boehringer Ingelheim fulfills economic development pledge to state
The $66 million project is part of the company's obligation made to the state after it moved here to invest a total of $120 ...
Eagle-Tribune1mon
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare ...
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...
Pharmabiz1d
Boehringer Ingelheim and MTM Vision join forces to combat vision loss from diabetes
Boehringer Ingelheim is a biopharmaceutical company active in both human and animal health. As one of the industry’s top investors in research and development, the company focuses on developing ...
pharmaphorum17d
One Health: The interconnection of animal and human health
“Only about two large pharmaceutical companies still have an animal health business,” he said. “Those are the US Merck or MSD and Boehringer Ingelheim. All the other companies, whether it ...
Yahoo Finance21d
Boehringer Ingelheim Expands Research and Development in Athens, Georgia
U.S. Animal Health Country Managing Director at Boehringer Ingelheim. "Each year, we invest nearly 12 percent of our sales into researching and developing products that will advance the health of ...
Campaign5y
OMD wins $100M global Boehringer Ingelheim Animal Health account
To receive full access to Campaign's content including: Unrestricted access to all The Information and The Knowledge content Access to Campaign's in-depth features and coveted reports including ...
World Rabies Day: Rabies can be prevented in humans and animals
Earlier this month, Boehringer Ingelheim, a leader in animal health, said it is stepping up its efforts to combat rabies in ...
Boehringer Ingelheim Limited: Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative join forces to combat vision loss from diabetes
More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of blindness in working-age adults. 1·DRD is a growing epidemic ...
Taiwan News1d
India Animal Vaccine Market Product Types, Animal Segments, and Administration Routes Forecast 2024-2032
Read the Market Summary Here @- India Animal Vaccine Market Size Zooming 3.6X at Healthy CAGR of More Than 7% to Surpass USD 4.87 Billion and 376.1 Million Doses by 2030 India Animal Vaccine Market ...
Financial Post1mon
Boehringer Ingelheim and WHO Foundation join forces to promote equitable access to healthcare and increase efforts for suicide prevention
Boehringer Ingelheim, a biopharmaceutical company active in both human and animal health, in partnership with WHO Foundation, today pledged USD 5 million to advance access to quality healthcare ...
Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative join forces to combat vision loss from diabetes
More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of ...